NCT00199979View on ClinicalTrials.gov

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

PHASE3UnknownINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

June 30, 2008

Conditions
Hiv Infection With Antiretroviral Therapy IndicationCD4 Below 350/µL or Below 15%
Interventions
DRUG

Nevirapine

Trial Locations (1)

67091

RECRUITING

Cisih, Clinique Medical A, Hopitaux Universitaires, Strasbourg

Sponsors

Lead Sponsor

MEDEX
All Listed Sponsors
lead

MEDEX

OTHER

NCT00199979 - Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients | Biotech Hunter | Biotech Hunter